Alexander Y. Walley, MD

Associate Professor, Medicine

Alexander Walley
(617) 414-6975
801 Massachusetts Ave Crosstown Center

Biography

Dr. Walley is the Director of the Boston University Addiction Medicine Fellowship Program and the Inpatient Addiction Medicine Consult Service at Boston Medical Center (BMC). He is a general internist and addiction expert who provides primary care for HIV-infected patients at BMC. His research interests include the medical complications of drug use, specifically HIV and overdose, the treatment of addictions with behavioral and pharmacologic interventions, and risk behaviors among HIV-infected people and people with HIV risk behaviors. He is an investigator on studies of the integration of addiction treatment into primary medical care and the implementation of an opioid overdose prevention programs.

He directs and founded a clinical program (FAST PATH) that integrates addiction treatment, into the medical care of patients who are HIV-infected or high-risk for HIV infection at Boston Medical Center. He founded the buprenorphine treatment program at Dimock Community Health Center in 2005. He previously served as the medical director of the Boston Public Health Commission methadone maintenance program. He is the medical director for the Massachusetts Department of Public Health’s Opioid Overdose Prevention Pilot Program. He completed a two year fellowship in general internal medicine in June 2007 and during that time he earned a Masters of Science degree in Epidemiology from BUSPH.

Other Positions

  • Courtesy Staff Privileges, Medicine, Boston Medical Center

Education

  • Johns Hopkins University School of Medicine, MD
  • Boston University School of Public Health, MSc
  • Harvard College, AB

Publications

  • Published on 10/23/2017

    Lorkiewicz SA, Ventura AS, Heeren TC, Winter MR, Walley AY, Sullivan M, Samet JH, Saitz R. Lifetime Marijuana and Alcohol Use, and Cognitive Dysfunction in People with Human Immunodeficiency Virus Infection. Subst Abus. 2017 Oct 23; 0. PMID: 29058572.

    Read at: PubMed
  • Published on 10/16/2017

    Kim TW, Walley AY, Ventura AS, Patts GJ, Heeren TC, Lerner GB, Mauricio N, Saitz R. Polypharmacy and risk of falls and fractures for patients with HIV infection and substance dependence. AIDS Care. 2017 Oct 16; 1-10. PMID: 29034725.

    Read at: PubMed
  • Published on 7/4/2017

    Fairbairn N, Coffin PO, Walley AY. Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: Challenges and innovations responding to a dynamic epidemic. Int J Drug Policy. 2017 Aug; 46:172-179. PMID: 28687187.

    Read at: PubMed
  • Published on 7/3/2017

    Morgan JR, Schackman BR, Leff JA, Linas BP, Walley AY. Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population. J Subst Abuse Treat. 2017 Jul 03. PMID: 28733097.

    Read at: PubMed
  • Published on 6/20/2017

    Edelman EJ, Lunze K, Cheng DM, Lioznov DA, Quinn E, Gnatienko N, Bridden C, Chaisson CE, Walley AY, Krupitsky EM, Raj A, Samet JH. HIV Stigma and Substance Use Among HIV-Positive Russians with Risky Drinking. AIDS Behav. 2017 Jun 20. PMID: 28634662.

    Read at: PubMed
  • Published on 5/19/2017

    Lasser KE, Hanchate AD, McCormick D, Walley AY, Saitz R, Lin MY, Kressin NR. Massachusetts Health Reform's Effect on Hospitalizations with Substance Use Disorder-Related Diagnoses. Health Serv Res. 2017 May 19. PMID: 28523674.

    Read at: PubMed
  • Published on 5/17/2017

    Nolan S, Walley AY, Heeren TC, Patts GJ, Ventura AS, Sullivan MM, Samet JH, Saitz R. HIV-infected individuals who use alcohol and other drugs, and virologic suppression. AIDS Care. 2017 Sep; 29(9):1129-1136. PMID: 28513200.

    Read at: PubMed
  • Published on 5/11/2017

    Trowbridge P, Weinstein ZM, Kerensky T, Roy P, Regan D, Samet JH, Walley AY. Addiction consultation services - Linking hospitalized patients to outpatient addiction treatment. J Subst Abuse Treat. 2017 Aug; 79:1-5. PMID: 28673521.

    Read at: PubMed
  • Published on 4/20/2017

    Bagley SM, Forman LS, Ruiz S, Cranston K, Walley AY. Expanding access to naloxone for family members: The Massachusetts experience. Drug Alcohol Rev. 2017 Apr 20. PMID: 28429378.

    Read at: PubMed
  • Published on 4/14/2017

    Somerville NJ, O'Donnell J, Gladden RM, Zibbell JE, Green TC, Younkin M, Ruiz S, Babakhanlou-Chase H, Chan M, Callis BP, Kuramoto-Crawford J, Nields HM, Walley AY. Characteristics of Fentanyl Overdose - Massachusetts, 2014-2016. MMWR Morb Mortal Wkly Rep. 2017 Apr 14; 66(14):382-386. PMID: 28406883.

    Read at: PubMed

View 63 more publications: View full profile at BUMC

View all profiles